Form 8-K - Current report:
SEC Accession No. 0001023024-06-000042
Filing Date
2006-11-14
Accepted
2006-11-14 15:10:26
Documents
3
Period of Report
2006-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR 3RD QUARTER thirdquarter8k.htm 8-K 28536
2 3RD QUARTER PRESS RELEASE q3pressrelease.htm EX-99.1 12748
3 PRESS RELEASE pressrelease1.jpg GRAPHIC 7689
  Complete submission text file 0001023024-06-000042.txt   53677
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 061214347
SIC: 2836 Biological Products, (No Diagnostic Substances)